Cancer cells may have inherent chemoresistance which allows an indefinite expansion. Transformed ovarian epithelial cells may undergo an immunoediting process. Immunoedited ovarian cancer drug-resistant cells escape first-line chemotherapy.
Epithelial ovarian cancer inherent resistance: May the pleiotropic interaction between reduced immunosurveillance and drug-resistant cells play a key role?
Lagana', Antonio Simone
Primo
;Sofo, Vincenza;Vitale, Salvatore Giovanni;Triolo, OnofrioUltimo
2016-01-01
Abstract
Cancer cells may have inherent chemoresistance which allows an indefinite expansion. Transformed ovarian epithelial cells may undergo an immunoediting process. Immunoedited ovarian cancer drug-resistant cells escape first-line chemotherapy.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Epithelial ovarian cancer inherent resistance.pdf
accesso aperto
Descrizione: Full text articolo pubblicato su rivista
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
127.62 kB
Formato
Adobe PDF
|
127.62 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
